Shhhh… avoiding acute crises in ‘silent disorders’
Medication adherence may be simple for acute, short-term diseases, but adherence becomes more difficult for chronic conditions when patients may not immediately realize the benefit of a treatment or intervention. Adherence is similarly difficult in patients with silent disorders, like hypertension, dyslipidemia or diabetes who are at risk of serious, life-threatening complications like stroke or heart attack. This presentation delve into the details of how to best treat patients with silent disorders who may be less likely to adhere to their treatment plans, click below to watch the session and learn more.
Speakers
Prof. Michael
Strupp
Germany
Prof. Joseph
Zohar
Israel
Prof. Atul
Pathak
Monaco
